Furthermore, an IL-6 inhibitor has been recently developed and used as a treatment for rheumatoid arthritis (RA) and Castleman’s disease, with results indicating that the adaptation and use of an IL-6 inhibitor were quite effective [12]. The gene discussed is IL6; the disease is rheumatoid arthritis.